<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000662464"><TermName>CP regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>A chemotherapy combination used to treat chronic lymphocytic leukemia (CLL). It includes the drugs chlorambucil hydrochloride and prednisone. Also called chlorambucil-prednisone, chlorambucil-prednisone regimen,  and CP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726244" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;CP regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726245" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen CP&quot;" language="es" id="_4"/><SpanishTermName>régimen CP</SpanishTermName><SpanishTermDefinition><DefinitionText>Quimioterapia combinada que se usa para tratar la leucemia linfocítica crónica (LLC). Incluye los medicamentos clorhidrato de clorambucilo y prednisona. También se llama clorambucilo-prednisona, CP,  y régimen de clorambucilo-prednisona.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-04-23</DateFirstPublished><DateLastModified>2010-12-28</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000686550">CHLORAMBUCIL-PREDNISONE</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
